Great West Life Assurance Co. Can lowered its position in shares of Bruker Co. (NASDAQ:BRKR) by 24.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,829 shares of the medical research company’s stock after selling 3,486 shares during the period. Great West Life Assurance Co. Can’s holdings in Bruker were worth $314,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. SG Americas Securities LLC purchased a new position in Bruker during the second quarter valued at approximately $101,000. Sun Life Financial INC purchased a new position in Bruker during the second quarter valued at approximately $163,000. TLP Group LLC purchased a new position in Bruker during the first quarter valued at approximately $190,000. Strs Ohio purchased a new position in Bruker during the second quarter valued at approximately $327,000. Finally, State of Alaska Department of Revenue grew its stake in Bruker by 35.6% during the second quarter. State of Alaska Department of Revenue now owns 11,510 shares of the medical research company’s stock valued at $334,000 after acquiring an additional 3,020 shares in the last quarter. 65.61% of the stock is owned by institutional investors.

BRKR stock opened at $32.87 on Monday. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.22 and a quick ratio of 1.27. Bruker Co. has a one year low of $28.13 and a one year high of $36.53. The company has a market capitalization of $5.14 billion, a price-to-earnings ratio of 25.48, a P/E/G ratio of 2.07 and a beta of 1.33.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Thursday, August 2nd. The medical research company reported $0.25 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.25. Bruker had a net margin of 4.99% and a return on equity of 27.03%. The business had revenue of $443.70 million during the quarter, compared to analysts’ expectations of $436.10 million. During the same quarter in the previous year, the company earned $0.23 EPS. The business’s quarterly revenue was up 6.9% compared to the same quarter last year. equities research analysts forecast that Bruker Co. will post 1.38 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, September 21st. Shareholders of record on Tuesday, September 4th were paid a $0.04 dividend. The ex-dividend date was Friday, August 31st. This represents a $0.16 dividend on an annualized basis and a yield of 0.49%. Bruker’s dividend payout ratio is presently 13.22%.

BRKR has been the subject of several recent analyst reports. ValuEngine raised shares of Bruker from a “sell” rating to a “hold” rating in a research note on Thursday, July 19th. Zacks Investment Research cut shares of Bruker from a “hold” rating to a “sell” rating in a research note on Tuesday, July 24th. BidaskClub cut shares of Bruker from a “buy” rating to a “hold” rating in a research note on Wednesday, September 19th. Finally, Morgan Stanley boosted their price target on shares of Bruker from $29.00 to $31.00 and gave the stock an “equal weight” rating in a research note on Friday, August 3rd. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $33.30.

Bruker Profile

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.

Featured Story: Outstanding Shares, Buying and Selling Stocks

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. (NASDAQ:BRKR).

Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.